These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22753293)

  • 1. [Chemotherapy for malignant tumors of lung and pleura].
    Rothschild S; Gautschi O
    Ther Umsch; 2012 Jul; 69(7):433-41. PubMed ID: 22753293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triplet chemotherapy combinations with new agents: is there a rationale?
    Bunn PA
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):55-61. PubMed ID: 9728586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemetrexed: a multitargeted antifolate.
    Rollins KD; Lindley C
    Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eve of the third millennium, providing an update on the management of non-small cell lung cancer (NSCLC).
    Le Chevalier T
    Anticancer Drugs; 2001 Jul; 12 Suppl 3():S1. PubMed ID: 11556248
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-angiogenic factors in thoracic oncology: successes, failures and prospects].
    Marco S; Tomasini P; Greillier L; Barlesi F
    Rev Mal Respir; 2011 Dec; 28(10):1216-29. PubMed ID: 22152931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatments for advanced stage non-small cell lung cancer.
    Stinchcombe TE; Socinski MA
    Proc Am Thorac Soc; 2009 Apr; 6(2):233-41. PubMed ID: 19349493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present trends in the treatment of advanced non small-cell lung cancer.
    Parvez T; Allam AR; Iskandrani A; Khan MA
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of advanced non-small cell lung cancer.
    Shepherd FA
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):7-18. PubMed ID: 8091244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new first-line therapeutic options for non-small-cell lung cancer.
    Crinò L; Foglietta J; Hamzaj A
    Lung Cancer; 2006 Dec; 54 Suppl 2():S19-24. PubMed ID: 17056151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.
    Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE
    Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage IV non small cell bronchial carcinoma; first line therapy in 2007].
    Lemarié E
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S101-7. PubMed ID: 18235401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in non-small cell lung cancer].
    Taillade L; Soria JC; André F; Grunenwald D; Dunant A; Pignon JP; Le Chevalier T
    Bull Cancer; 2004 Jan; 91(1):63-7. PubMed ID: 14975806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy and age-related biases in non-small cell lung cancer.
    Rodriguez KA; Guitron J; Hanseman DJ; Williams V; Starnes SL
    Ann Thorac Surg; 2012 Dec; 94(6):1810-4. PubMed ID: 23103001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.